Impact on Survival of Pretransplant Portal Vein Thrombosis

M Librero Jiménez; M A López Garrido; M Herrador Paredes

doi:10.1016/j.transproceed.2021.11.004

Impact on Survival of Pretransplant Portal Vein Thrombosis

Transplant Proc. 2022 Jan-Feb;54(1):35-36. doi: 10.1016/j.transproceed.2021.11.004. Epub 2021 Dec 29.

Authors

M Librero Jiménez¹, M A López Garrido², M Herrador Paredes²

Affiliations

¹ Hepatology Department, Virgen de las Nieves University Hospital, Granada, Spain. Electronic address: marlibjim@gmail.com.
² Hepatology Department, Virgen de las Nieves University Hospital, Granada, Spain.

PMID: 34973838
DOI: 10.1016/j.transproceed.2021.11.004

Abstract

Portal vein thrombosis (PVT) still remains a major challenge in managing liver transplant recipients. The aim of this study was to describe PVT prevalence in our health district and identify potential risk factors involved. Although further research is needed to make some general appointments, we identified anticoagulation therapy before transplant as a potential protective factor against PVT.

MeSH terms

Humans
Liver Cirrhosis / pathology
Liver Transplantation*
Portal Vein / diagnostic imaging
Portal Vein / pathology
Retrospective Studies
Venous Thrombosis* / etiology
Venous Thrombosis* / pathology